問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCAMG334A2304
Completed

2019-08-19 - 2024-04-30

Phase III

Recruiting2

Terminated7

  • Trial Applicant

    NOVARTIS (TAIWAN) CO., LTD.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Shuu-Jiun Wang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 楊鈞百

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 陳律安

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 楊富吉

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Long-Sun Ro

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 許永居

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 林高章

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Kang-Hsu Lin

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    145 participants

  • Global

    557 participants